Bill Wickline is the managing director of Bridge Bank's Life Sciences Group. He provides term debt and revolving credit facilities to US-based life sciences companies for a variety of purposes, including growth capital, working capital, refinancing, restructuring, recapitalization, as well as mergers and acquisitions. Based in San Diego, he serves clients in biopharmaceutical, medical devices, medical diagnostics/tools industries and more in his role leading the life sciences group.
Mr. Wickline was a co-founder of Bridge Bank’s national life sciences practice in 2015. Comprised of multiple lenders with significant industry experience, our group focuses on adding value to companies in all life sciences verticals and stages of development. Prior to joining Bridge Bank, Bill held a leadership role in the underwriting and portfolio management group at Oxford Finance LLC, helping to grow their west coast practice over 500%.
He holds a MBA from the Rady School of Management at UCSD (graduating with the inaugural full-time class in 2007) and a MS in Management Science with distinguished honors from UCSD.
Bridge Bank’s Life Sciences Group delivers tailored financial lending solutions, alongside outstanding service, to innovators nationwide as they bring their products from lab to market. Experienced, knowledgeable relationship managers understand the unique challenges and opportunities life science companies face in all stages of their growth trajectory and provide sophisticated products and services that make a difference. Bridge Bank is part of Western Alliance Bancorporation, which has more than $65 billion in assets and ranked #1 among top-performing large banks in 2021 by both American Banker and Bank Director.